Interestingly, even lean MASLD patients show decreased adiponectin levels, a finding which is still not understood and probably reflects a complex interplay between the adipose tissue and the liver [56]. This evidence concerns the gene ADIPOQ and metabolic dysfunction-associated steatotic liver disease.